Thi Ly Le | Impact Mechanics | Best Researcher Award

Published on by Mechanics Awards

Dr. Thi Ly Le | Impact Mechanics | Best Researcher Award 

Doctorate, at University of Science and Technology of Hanoi, Vietnam Academy of Science and Technology, Vietnam.

Dr. Lê Thị Lý (born July 3, 1986) is a Lecturer at the Department of Fundamental and Applied Science, University of Science and Technology of Hanoi (USTH), since July 2017. She earned her PhD in Materials Science & Engineering from Toulouse 3 – Paul Sabatier University, France, in September 2016. Her work focuses on advanced materials and catalytic processes for energy conversion, particularly CO₂ reduction and photoelectrocatalysis. Dr. Ly teaches solid‑state chemistry and project‑based energy materials courses at USTH, contributing actively to both education and materials research. She is involved in national and institutional research programs and holds multiple scientific project secretary roles for NAFOSTED and VAST initiatives. Her academic trajectory reflects strong international training and impactful contributions to sustainable energy materials in Vietnam.Trường Hóa và Khoa học Sự sống+10USTH+10USTH+10

Professional Profile

Scopus

Google Scholar

🎓 Education

Dr. Lý began her academic journey with a Bachelor’s degree in Physics from Hanoi University of Science, graduating in June 2009. She pursued a Master’s in Nuclear Physics and Applications at Bordeaux 1 University, France, completing in June 2012. Her doctoral studies were conducted at Toulouse 3 – Paul Sabatier University, France, culminating in a PhD in Materials Science and Engineering in September 2016. Her education emphasizes international scientific training, especially in physical sciences and materials engineering. These qualifications prepared her for a career in electrocatalysis and energy‑related materials research, and underpin her teaching and project leadership at USTH.USTHUSTH

🧠 Experience

Since July 2017, Dr. Lý has held a Lecturer position at USTH’s Department of Fundamental and Applied Science. Over the past five years, she served as Scientific Secretary or key member on multiple funded projects, including two NAFOSTED research programs on photoelectrodes for water splitting (2020–2024, 2024–2027) and several projects on photocatalysts and CO₂ reduction supported by VAST and Vietnam’s Ministry of Science and Technology. She coordinated investigations into copper‑based CO₂ reduction catalysts, artificial leaf devices, and spinel nanomaterials. These roles reflect her leadership in large‑scale national research efforts, project coordination, and hands‑on scientific contributions in electrocatalytic materials.USTHUSTH

🔬 Research Interests

Dr. Lý’s primary research spans materials science and engineering, focusing on electrocatalysts and photoelectrocatalysts for energy conversion and storage. She investigates novel catalytic systems for CO₂ reduction and water splitting, particularly copper‑based and semiconductor nanomaterials. Her recent projects include fabrication of photoelectrodes based on modified n‑type semiconductors aimed at hydrogen generation, earth‑abundant element photocatalysts for artificial leaf devices, and chalcogenide electrocatalysts (MS/MSe) for energy conversion. She explores mechanistic aspects of material performance, aiming to integrate materials design into complete devices for sustainable fuel production.USTHUSTH

🏆 Awards

There are no publicly listed personal awards or honors for Dr. Lý on institutional or national webpages, including USTH profiles and project summaries reviewed. While she holds leadership and coordination roles in competitive national research grants (e.g., NAFOSTED and Ministry‑funded projects), specific individual awards were not indicated in accessible sources.Đào tạo tiến sĩ – USTH+2mica.edu.vn+2Trường Hóa và Khoa học Sự sống+2

📚 Top Noted Publications

Here are a few recent peer‑reviewed journal articles (year, journal, co‑authors), with hyperlinks:

1. “Decoration of AgOx hole collector to boost photocatalytic water oxidation activity of BiVO₄ photoanode” (Materials Today Energy, 2021)

Authors: Hoang V. Le, Minh D. Nguyen, Y.T.H. Pham, D.N. Nguyen, L.T. Le, H. Han, P.D. Tran

  • Presents a strategy where an ultrathin layer of AgOx is deposited onto a BiVO₄ photoanode.

  • AgOx acts as a hole collector, facilitating the extraction of photogenerated holes from the BiVO₄ and improving charge separation and transfer at the surface.

  • The modification substantially enhances the photoelectrochemical water oxidation activity compared to bare BiVO₄.

  • Published in Materials Today Energy with DOI: 10.1016/j.mtener.2021.100762 pubs.rsc.org+14vienkhcn.tnus.edu.vn+14OUCI+14OUCI

2. “Fabrication of tungsten oxide photoanode… investigation on its photocatalytic mechanism” (International Journal of Hydrogen Energy, Volume 46 Issue 44, pp. 22852–22863, 2021)

Authors: Hoang V. Le, P.T. Pham, L.T. Le, A.D. Nguyen, N.Q. Tran, P.D. Tran

  • Reports the preparation of WO₃-based photoanodes.

  • Analyzes the photocatalytic behavior and mechanistic pathways for water oxidation under solar illumination, focusing on how WO₃ structural and surface properties influence performance.

  • Explores charge carrier dynamics, surface state energetics, and reaction intermediates to explain efficiency variations.

  • Indexed in Int. J. Hydrogen Energy (2021, 46–44, pp 22852–22863).

3. “Investigation on the growth mechanism of Cu₂MoS₄ nanotube, nanoplate and its use as a catalyst for hydrogen evolution” (Chemistry – An Asian Journal, 2020, 15:1873–1880)

Authors: L.T. Le et al.

  • Examines the synthesis of Cu₂MoS₄ nanostructures, notably nanotubes and nanoplates, via self‑assembly under hydrothermal conditions.

  • Investigates how parameters such as precursor concentration, temperature, and time affect morphology and crystal-growth mechanisms.

  • Evaluated these nanostructures as electrocatalysts for the hydrogen evolution reaction (HER).

  • Revealed relationships between morphology, surface area, and catalytic activity—especially how high-aspect-ratio nanotubes or nanoplates promote more active sites and better performance in HER.

Conclusion 

Dr. Le Thi Ly demonstrates high scientific merit and a focused, productive research trajectory in advanced materials for energy and environmental applications. Her consistent output, leadership roles in research projects, and international publications make her a strong candidate for the Best Researcher Award.

Yosuke Komatsu | Intelligent Materials | Best Researcher Award

Published on by Mechanics Awards

Dr. Yosuke Komatsu | Intelligent Materials | Best Researcher Award 

Resercher, at Institute of Health Sciences, Kirin Holdings Co., Ltd, Japan.

Yosuke Komatsu is a distinguished scientist currently affiliated with KIRIN Holdings Company Limited, Health Science Research Institute, where he leads projects in nutrition and gut microbiota. With training in pharmaceutical and life sciences from Hokkaido University, he brings multidisciplinary expertise in metabolomics, protein science, and prebiotics. Komatsu’s innovative work centers on how human milk oligosaccharides (HMOs) and dietary proteins influence gut microbial metabolism, nutrient absorption, and infant growth. He has authored numerous peer‑reviewed publications in high‑impact journals, combining advanced NMR metabolomic techniques and in vitro digestion models. His research elucidates cross‑feeding mechanisms in the gut microbiome and the nutritional quality of protein sources ranging from milk to insects. With a strong track record in publication, patent development, and conference presentations, he is poised to contribute novel insights into human health, nutritional biomarkers, and early‑life diet interventions. Komatsu is widely respected for bridging basic science and applied nutrition research.

Professional Profile

ORCID

🎓 Education

Yosuke Komatsu earned all his degrees at Hokkaido University in Japan. He completed his Bachelor’s degree (2004–2008) in Integrated Pharmaceutical Sciences within the School of Pharmaceutical Sciences, followed by a Master’s program (2008–2010) at the Graduate School of Pharmaceutical Sciences. He then pursued a PhD (2018–2021) in Life Sciences at the Graduate School of Life Science. During his doctoral studies, Komatsu worked under the Soft Matter Science group, focusing on protein digestibility and nutritional metabolism using advanced analytical methods. His academic training provided him with rigorous grounding in pharma, metabolomics, and nutritional science, fostering his ability to conduct interdisciplinary research. His education set the foundation for later innovation in human milk oligosaccharide research and protein evaluation. It enabled him to integrate pharmaceutical insights with nutritional outcomes demonstrated through in vitro digestion models, NMR metabolomics, and gut microbiome analysis, culminating in a robust research portfolio.

💼 Experience

Yosuke Komatsu has built a solid research career in Japan’s nutrition and food science industry as well as academia. Since June 2024, he has been at KIRIN Holdings, Health Science Research Institute, where he oversees studies on prebiotics, human milk oligosaccharides, and metabolomics. From November 2015 to May 2024, he worked at Morinaga Milk Industry’s Health and Nutrition Science Institute, developing projects related to protein digestibility, dietary amino acid balance, and gut health. Simultaneously, he held adjunct roles at Juntendo University (Apr 2023–Mar 2024) and Hokkaido University (Apr 2017–Mar 2024), bridging academic research and industry. Earlier, from April 2010 to October 2015, he was at Morinaga’s Tokyo Tama Factory. Across these roles, Komatsu has led both laboratory-based and translational studies, supervised student training, collaborated across institutions, and guided patent filings. His experience uniquely blends industrial research, academic collaboration, and leadership in research dissemination through publications and presentations.

🔬 Research Interests

Yosuke Komatsu focuses on the intersection of nutrition, gut microbiota, and protein science. His work encompasses: (1) Prebiotics and Human Milk Oligosaccharides (HMOs)—exploring how HMOs support beneficial gut bacteria like Faecalibacterium prausnitzii via cross‑feeding mechanisms; (2) Protein digestibility and nutritional quality—comparing human milk, formula, plant, insect, and casein proteins under infant digestion models (INFOGEST); (3) Metabolomics and gut microbial metabolites—using NMR to identify biomarkers responsive to protein undernutrition or maternal diet; (4) Nutrition biomarkers such as albumin redox state and urinary taurine to assess protein status. He applies integrative metabolomic, microbiome, transcriptomic, and in vitro digestion techniques. His aim is to elucidate how early‑life nutrition influences microbial ecology, infant growth, and long‑term metabolic health, bridging molecular insights to practical dietary interventions.

🏆 Award

Yosuke Komatsu’s excellent research communication was recognized in August 2023, when he received the Outstanding Presentation Award at the 11th Annual Meeting of the Japan DOHaD Society. This accolade highlighted his oral presentation on maternal diet, human milk nutrient composition, and infant growth outcomes, demonstrating clarity, scientific depth, and relevance to developmental origins of health and disease. The award underscores his ability to present complex findings—such as links between maternal nutrition, HMOs, and infant growth trajectories—in an engaging, compelling manner to expert audiences. This recognition reflects his dedication to advancing nutritional science and his effectiveness as a science communicator. He has also delivered invited lectures at prominent conferences, including the IDF World Dairy Summit and international metabolomics symposia. Together, his award and speaking engagements illustrate both his scientific excellence and his leadership in disseminating research results to diverse scholarly communities.

📚 Top Noted Publications

Below are some of Komatsu’s major publications, each listed with year, journal, and citation link:

Haruka Onodera, Yohei Sato, Yosuke Komatsu, Makoto Yamashita, et al. (2025). “HMOs Induce Butyrate Production of Faecalibacterium prausnitzii via Cross‑Feeding by Bifidobacterium bifidum with Different Mechanisms for HMO Types.” Microorganism. Cited by: [single‑line citations needed] 🔗 (2025).
Keiko Motokawa, Maki Shirobe, … Yosuke Komatsu. (2024). “Is urinary taurine associated with protein intake? Itabashi Longitudinal Study on Aging.” Geriatrics & Gerontology International. Cited by: … 🔗
Yosuke Komatsu, Yasuaki Wada, … “Comparison of protein digestibility of human milk and infant formula using the INFOGEST method under infant digestion conditions.” The British Journal of Nutrition (2024). Cited by: … 🔗
Yosuke Komatsu, Muneya Tsuda, … “Nutritional Evaluation of Milk‑, Plant‑, and Insect‑Based Protein Materials by Protein Digestibility Using the INFOGEST Digestion Method.” Journal of Agricultural and Food Chemistry (2023). Cited by: … 🔗
Yosuke Komatsu … (2023). “Associations between Maternal Diet, Human Milk Macronutrients, and Breast‑Fed Infant Growth during the First Month of Life in the SMILE Iwamizawa in Japan.” Nutrients. Cited by: … 🔗

1. Baseline Digestibility Studies

Komatsu Y, Wada Y, Shibasaki T, Kitamura Y, Ehara T, Nakamura H & Miyaji K. (2024). Comparison of protein digestibility of human milk and infant formula using the INFOGEST method under infant digestion conditions. British Journal of Nutrition, published online 3 June 2024; Volume 132(3): pp 1–26. DOI: 10.1017/S0007114524001260. PMID: 38826083. Affiliation: Morinaga Milk Industry Co., Ltd., Kanagawa, Japan ACS Publications+2OUCI+2Cambridge Core+2.

2. Broad Protein Source Evaluation

Komatsu Y, Tsuda M, Wada Y, Shibasaki T, Nakamura H & Miyaji K. (2023). Nutritional Evaluation of Milk‑, Plant‑, and Insect‑Based Protein Materials by Protein Digestibility Using the INFOGEST Digestion Method. Journal of Agricultural and Food Chemistry, 71(5): 2503–2513, published 25 January 2023. DOI: 10.1021/acs.jafc.2c07273. PMID: 36695832. Affiliations: Morinaga Milk Industry Co., Ltd., and Hokkaido University collaboration ACS PublicationsPubMed.

3. Maternal Diet & Infant Growth

Komatsu Y, Wada Y, Tabata F, Kawakami S, Takeda Y, Nakamura K, Ayabe T, Nakamura K, Kimura T & Tamakoshi A. (2023). Associations between Maternal Diet, Human Milk Macronutrients, and Breast‑Fed Infant Growth during the First Month of Life in the SMILE Iwamizawa in Japan. Nutrients, 15(3): 654 (Open Access, published 28 January 2023). DOI: 10.3390/nu15030654 MDPI森永乳業ウェブサイト.

4. Studies Still Pending Full Indexing

  • Onodera H, Sato Y, Komatsu Y, Yamashita M, et al. (2025). HMOs Induce Butyrate Production of Faecalibacterium prausnitzii via Cross‑Feeding by Bifidobacterium bifidum with Different Mechanisms for HMO Types. Microorganism (2025). Not yet indexed in major citation databases.

  • Motokawa K, Shirobe M, et al. including Komatsu Y. (2024). Is Urinary Taurine Associated with Protein Intake? Itabashi Longitudinal Study on Aging. Geriatrics & Gerontology International (2024). No citation metadata visible in standard scholarly indexes.

Conclusion

Dr. Yosuke Komatsu is highly deserving of consideration for the Best Researcher Award. His contributions are significant in advancing nutritional sciences, particularly in understanding protein quality, maternal-infant health, and microbiome interactions. He has a well-rounded portfolio of peer-reviewed research, translational patents, academic engagements, and presentations.

Prof. Hala Fouad Ahmed Mohamed | Molecular biology | Best Researcher Award

Published on by Mechanics Awards

Prof. Hala Fouad Ahmed Mohamed | Molecular biology | Best Researcher Award

Prof. Hala Fouad Ahmed Mohamed, Al-Azhar university, Faculty of science, Department of botany and microbiology, Egypt.

Dr. Hala Fouad Ahmed Mohamed is a distinguished molecular biologist and microbiologist from Cairo, Egypt. She earned her Bachelor of Science in Microbiology with distinction and honors from Al-Azhar University. She later received a fully funded Egyptian government scholarship to pursue her PhD in Molecular Biology at the University of Sheffield, United Kingdom. Dr. Hala has significant expertise in microbial genomics, secondary metabolites, peptide synthesis, and bioinformatics. Fluent in both Arabic and English, she continues to make impactful contributions in research and higher education while residing in First Settlement, Cairo.

Professional Profile

Scopus

Education and Experience

Dr. Hala received her Bachelor of Science in Microbiology from Al-Azhar University in 1998, graduating with distinction and honors. She completed a pre-master course in the Botany and Microbiology Department at the same university in 1999 with distinction. In 2001, she was awarded a fully funded Egyptian government scholarship to pursue a PhD in Molecular Biology, which she earned from the University of Sheffield in 2005. Her postdoctoral research has focused on marine microbial metagenomics, the isolation and identification of microbial secondary metabolites, protein peptide synthesis, and bioinformatic analysis of nucleic acid and protein sequences.

Summary Suitability

Prof. Hala Fouad Ahmed Mohamed is a highly qualified candidate for the Best Researcher Award, with over two decades of impactful contributions to molecular biology, microbiology, and environmental biotechnology. As an Associate Professor at Al-Azhar University and a foreign expert at the Third Institute of Oceanography in China, she has demonstrated exceptional leadership in both academic and applied research environments. Her current directorship of a major project on coral microbiome and restoration using metagenomic and metatranscriptomic tools highlights her commitment to solving pressing environmental challenges through molecular innovation.

Professional Development

Dr. Hala has engaged in continuous professional development. While at the University of Sheffield, she completed several advanced courses, including those on fungal genetics, gene cloning, metagenomic and metatranscriptomic analysis, microarray technologies, and bioinformatics. She also received training in statistical analysis and interpersonal communication. Her laboratory expertise extends to the use of HPLC, mass spectrometry, and NMR for the isolation and characterization of natural products. This combination of theoretical learning and practical laboratory skills has strengthened her capacity for interdisciplinary research in molecular biology and microbiology.

Research Focus

Dr. Hala’s research is centered on microbial genomics and the study of secondary metabolism, particularly in Aspergillus fumigatus. She has explored the use of metagenomics and metatranscriptomics to analyze marine microbial communities and discover novel bioactive compounds. Her work includes the chemical synthesis of peptides and the identification of microbial natural products using advanced techniques such as HPLC, mass spectrometry, and NMR. She also conducts comprehensive bioinformatic analyses of DNA, RNA, and protein data. Her research has significant implications in drug discovery, environmental microbiology, and industrial biotechnology through the identification of new and useful microbial metabolites.

Awards and Honors:

Dr. Hala received a fully funded Egyptian government scholarship in 2001 to pursue her PhD studies in the United Kingdom. She graduated with distinction and honors in her Bachelor of Science degree in Microbiology from Al-Azhar University in 1998. Additionally, she completed her pre-master course in botany and microbiology with distinction in 1999.

Publication Top Notes

  1. Hala F. Mohamed and Xiaohui Sun
    Title: Enhanced Antiviral Activity of Isolated Streptomyces avermitilis Extract in Conjugation with Gold Nanoparticles
    Journal: Egyptian Journal of Chemistry
    Year: 2022 (In Press)

  1. Mohamed H. F., Abd-Elgawad A., Cai R., Luo Z., Xu C.
    Title: The Bacterial Signature Offers Vision into the Machinery of Coral Fitness Across High-Latitude Coral Reef in the South China Sea
    Journal: Environmental Microbiology Reports
    Year: 2023

  1. Yi Zhu, Yuansen Liu, Hala F. Mohamed, Xinqing Zheng, Jianlin He, Ling Lin
    Title: Rigid, Eco-friendly and Superhydrophobic SiO₂–Polyvinyl Alcohol Composite Sponge for Durable Oil Remediation
    Journal: Chemosphere
    Year: 2022

  1. Lulu Pei, Wenjia Hub, Pengbin Wang, Hala F. Mohamed, Changyou Wang, Lemian Liu, Zhaohe Luo
    Title: Morphologic and Phylogenic Characterization of Two Bloom-Forming Planktonic Prorocentrum (Dinophyceae) Species and Their Potential Distribution in the China Sea
    Journal: Algal Research
    Year: 2022

  1. Mohamed H. F., Chen Y., Abd-Elgawad A., Cai R., Xu C.
    Title: The Unseen Drivers of Coral Health; Coral Microbiome; The Hope for Effective Coral Restoration
    Journal: Polish Journal of Environmental Studies
    Year: 2022

  1. Kang Jianhua, Luo Zhaohe, Mohamed Hala F., Lin Yili, Huang Shuhong, Wang Yu, Lan Wenlu
    Title: Environmental Regulation of Photosynthetically Produced Dissolved Organic Carbon by Phytoplankton Along a Subtropical Estuarine Bay
    Journal: Frontiers in Marine Science
    Year: 2022

Conclusion

Dr. Hala Fouad Ahmed Mohamed exemplifies the qualities of a Best Researcher Award recipient through her scientific innovation, impactful publications, leadership in international research initiatives, and sustained dedication to environmental and microbial sciences. Her work continues to influence the direction of molecular biology and environmental restoration, marking her as a truly distinguished contributor to her field.

 

Dr. Anis Ahmad Chaudhary | Bio materials | Best Researcher Award

Published on by Mechanics Awards

Dr. Anis Ahmad Chaudhary | Bio materials | Best Researcher Award

Dr. Anis Ahmad Chaudhary, Imam Mohammad Ibn Saud Islamic University, Saudi Arabia.

Dr. Anis Ahmad Chaudhary is an Associate Professor at the College of Science, Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia. He earned his Ph.D. in Biotechnology from Jamia Hamdard, India, where he focused on developing molecular markers for authenticating medicinal plants. His academic journey includes positions as Assistant Professor at the College of Medicine and earlier roles as a DST Young Scientist and CSIR-SRF in India. Dr. Chaudhary has contributed significantly to research in plant biotechnology and pharmacognosy, combining molecular biology with traditional medicine. His work reflects a strong commitment to teaching, research, and academic excellence.

Professional Profile

Scopus
Orcid
Google Scholar

Education and Experience

Dr. Chaudhary holds a Ph.D. in Biotechnology from Jamia Hamdard, New Delhi; an M.Sc. in Biotechnology  from Jamia Millia Islamia, New Delhi; and a B.Sc. in Biological Science  from CCS University, Meerut. He is currently serving as an Associate Professor at the College of Science, Imam Mohammad Ibn Saud Islamic University. Before his academic tenure in Saudi Arabia, he worked as a DST Young Scientist at Jamia Millia Islamia, and as a Senior and Junior Research Fellow at Jamia Hamdard.

Summary Suitability

Dr. Anis Ahmad Chaudhary is an outstanding candidate for the Best Researcher Award due to his exemplary contributions in the field of molecular biology and biotechnology, particularly in the authentication of medicinal plants using LAMP-based molecular markers. As an Associate Professor at the College of Science, Imam Mohammad Ibn Saud Islamic University, Riyadh, Dr. Chaudhary has consistently demonstrated excellence in research, academic leadership, and innovation. His research bridges traditional medicine and advanced molecular diagnostics, addressing key issues in herbal drug standardization and quality control, which are of immense relevance in both academic and industrial spheres.

Professional Development

Dr. Chaudhary’s professional growth showcases a consistent dedication to biotechnology and pharmacognosy. He began his scientific career in India, undertaking research fellowships that focused on molecular diagnostics. His award under the DST Young Scientist program highlighted his expertise in developing rapid and accurate methods for medicinal plant authentication. Transitioning to academia in Saudi Arabia, he has contributed to both teaching and research while mentoring students and guiding innovative projects. His work integrates traditional herbal medicine with cutting-edge molecular tools, underscoring his role in advancing quality assurance and standardization in natural product research.

Research Focus 

Dr. Anis Ahmad Chaudhary’s research focuses on plant molecular biology, particularly the development of LAMP-based molecular markers for the authentication of medicinal plants. His work aims to merge the fields of traditional herbal medicine with modern biotechnological approaches. He specializes in DNA barcoding, molecular diagnostics, and herbal drug standardization, ensuring the traceability and purity of plant-based formulations. His interdisciplinary research contributes to the fields of pharmacognosy, genetic marker development, and biotechnology for natural product analysis. Dr. Chaudhary’s research has significant relevance in both academic and industrial settings, particularly in ensuring the authenticity and safety of herbal medicines.

Awards and Honors

Dr. Anis Ahmad Chaudhary has been honored with the DST Young Scientist Award by the Department of Science and Technology, Government of India, in recognition of his contributions to molecular diagnostics. He has also been awarded the Senior Research Fellowship (SRF) by the Council of Scientific and Industrial Research (CSIR) and the Indian Council of Medical Research (ICMR), and the Junior Research Fellowship (JRF) at Jamia Hamdard. His innovative research in the field of plant authentication and pharmacognosy has earned him national recognition. In addition to his fellowships, he has authored several research publications and remains a respected figure in the field of biotechnology.

Publication Top Notes

1. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050

Authors: M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, et al.
Journal: The Lancet
Volume: 404
Issue: 10459
Pages: 1199–1226
Year: 2024
Citations: 1068

2. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

Authors: SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, et al.
Journal: The Lancet
Volume: 403
Issue: 10440
Pages: 2204–2256
Year: 2024
Citations: 452

3. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Authors: VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, et al.
Journal: The Lancet Neurology
Volume: 23
Issue: 10
Pages: 973–1003
Year: 2024
Citations: 326

4. Down‐Regulation of Hypothalamic Kisspeptin and its Receptor, Kiss1r, mRNA Expression is Associated with Stress‐Induced Suppression of Luteinising Hormone

Authors: JS Kinsey‐Jones, XF Li, AMI Knox, ES Wilkinson, XL Zhu, AA Chaudhary, et al.
Journal: Journal of Neuroendocrinology
Volume: 21
Issue: 1
Pages: 20–29
Year: 2009
Citations: 229

5. Novel approach: Herbal remedies and natural products in pharmaceutical science as nano drug delivery systems

Authors: D Yadav, S Suri, AA Choudhary, M Sikender, BN Hemant, NM Beg
Journal: International Journal of PharmTech Research
Volume: 3
Issue: 3
Pages: 3092–3116
Year: 2011
Citations: 174

6. FNDC5/Irisin: physiology and pathophysiology

Authors: R Waseem, A Shamsi, T Mohammad, MI Hassan, SN Kazim, et al.
Journal: Molecules
Volume: 27
Issue: 3
Article Number/Page: 1118
Year: 2022
Citations: 157

7. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021

Authors: M Ng, E Gakidou, J Lo, YH Abate, C Abbafati, N Abbas, M Abbasian, et al.
Journal: The Lancet
Volume: 405
Issue: 10481
Pages: 813–838
Year: 2025
Citations: 133

Conclusion

Dr. Anis Ahmad Chaudhary’s scholarly achievements, innovative methodologies, and dedication to research excellence make him a highly deserving nominee for the Best Researcher Award. His work addresses globally significant challenges in health and natural product sciences, and his commitment to academic development continues to inspire students and peers alike. Recognizing him with this award would not only honor his contributions but also encourage continued excellence in the fields of molecular biotechnology and medicinal plant research.

Ryszard Pluta | Medicine | Best Researcher Award

Published on by Mechanics Awards

Prof. Dr. Ryszard Pluta | Medicine | Best Researcher Award 

Professor, at Department of Pathophysiology, Medical University of Lublin, Poland,

Professor Ryszard Pluta, M.D., Ph.D., is a distinguished neuropathologist whose career spans over four decades. He earned his M.D. from the Medical Academy in Lublin, Poland , followed by advanced fellowships at Humboldt University in Berlin  and the University of Cologne (1976). He earned his Ph.D. from the Polish Academy of Sciences in Warsaw in 1983, was promoted to Associate Professor in 1992, and served as Full Professor at the Mossakowski Medical Research Institute (2004–2022). Internationally recognized, he held postdoctoral fellowships at the U.S. National Institutes of Health (1986–1988) and New York State Institute for Basic Research (1988–1989), and has been Visiting Professor at prestigious institutions in the U.S. and Europe. His groundbreaking contributions to understanding Alzheimer’s disease, particularly its ischemic and autoimmune underpinnings, have earned him global acclaim and inclusion in Stanford’s Top 2% of scientists.

Professional Profile

Scopus

ORCID

🎓 Education

Ryszard Pluta began his medical journey at the Medical Academy in Lublin, Poland, where he obtained his M.D. between 1971 and 1977. Eager to deepen his expertise, he pursued fellowships in neuropathology and neuroscience at Humboldt University in Berlin in 1975 and at the University of Cologne in 1976. His academic pursuits led him to the Polish Academy of Sciences in Warsaw, where he earned a Ph.D. in 1983, establishing a strong foundation in research and clinical neurology. In 1992, he defended his Associate Professor thesis and later achieved Full Professor status in 2004 at the Mossakowski Medical Research Institute, where he served until 2022. He also broadened his scholarly horizons through international postdoctoral training and Visiting Professorships, including stints at NIH (Bethesda, 1986–1988), the New York State Institute for Basic Research (1988–1989), and multiple European universities. His rich and diverse academic background underpins his pioneering work in Alzheimer’s disease.

💼 Experience 

Professor Pluta’s career is marked by a blend of clinical, research, and educational roles. From 2004 to 2022, he led as Full Professor at the Mossakowski Medical Research Institute, Polish Academy of Sciences in Warsaw, steering groundbreaking neuroscience research. Earlier, he held the title of Associated Professor from 1992, following his Ph.D. achievement in 1983. His international footprint includes postdoctoral positions at the NIH in Bethesda (1986–1988) and the New York State Institute for Basic Research in Staten Island (1988–1989). He later served as Visiting Professor across leading institutions: New York State Institute (1990/1991, 1993/1994, 1997), Max‑Planck Institute for Neurological Research in Cologne (2000, 2001, 2003), University of Belgrade (2010), Charles University in Prague–Pilsen (2011), Maria Curie‑Skłodowska University (2017), and currently Medical University of Lublin (2023–present). Globally engaged, his rich experience spans teaching, international collaboration, and high-impact research initiatives.

🔬 Research Interest 

Professor Pluta’s primary research interest lies in unraveling the mechanisms of Alzheimer’s disease through an ischemic lens. In 1994, he was the first to propose that cerebral ischemia plays a critical role in the etiology of Alzheimer’s disease, challenging prevailing paradigms. His current work focuses on detailed in vivo ischemic models that track proteomic and genomic alterations mirroring Alzheimer’s neuropathology. He investigates the sequence of molecular events—gene expression changes, protein aggregation, and neural degeneration—driven by ischemia, aiming to uncover the cascade leading to Alzheimer’s phenotype development. Additionally, he pioneered autoimmune therapeutic strategies for Alzheimer’s, exploring how immunomodulation can mitigate disease progression. His present studies delve into ischemia-triggered gene regulation and pathological outcomes, seeking targets for therapeutic intervention. His research bridges neuropathology, molecular biology, and translational therapy development in Alzheimer’s, positioning him as a leader in the interdisciplinary study of neurodegeneration.

🏆 Awards 

Professor Pluta’s remarkable contributions have been recognized through numerous prestigious awards: He received honors from the Polish Association of Neuropathologists in 1980 and 1986. In 1982 and 1989, he was acknowledged by the President of the Polish Academy of Sciences. The Medical Secretary of the Polish Academy of Sciences conferred another award upon him in 1992. In 1996, the Batory Foundation in Warsaw recognized his excellence, followed by acclaim from the International Brain Research Organization in Paris in 1997. The Alzheimer’s Association in Chicago honored him in 1998 for his innovative autoimmune therapy proposal. He was celebrated at the Neuroscience Conference ’11 in 2011 and received the Maria Curie‑Skłodowska Statuette in 2017. These awards reflect his pioneering work in neuropathology and Alzheimer’s research, spanning national and international stages.

📚 Top Noted Publication 

Professor Pluta has authored over 300 peer-reviewed articles reflecting his contributions to neuroscience. Noteworthy publications include his seminal 1994 paper describing the ischemic hypothesis of Alzheimer’s disease and his pioneering 1998 autoimmune therapy proposal. His studies often appear in high-impact journals, elucidating how ischemic brain injury mirrors Alzheimer’s pathology at genetic and proteomic levels. Recent works detail in vivo ischemic Alzheimer’s models outlining gene expression changes leading to amyloid and tau pathology. Pluta’s research integrates cutting-edge methods—proteomics, genomics, and molecular neuropathology—to trace ischemia-induced neurodegeneration. His findings have been widely cited, advancing the field’s understanding of vascular contributions to Alzheimer’s disease. Renowned in scientific circles, his ongoing investigations into ischemia-triggered gene regulation and disease phenotype progression continue to shape strategies for early diagnosis and therapeutic development. Professor Pluta remains one of the most influential voices in Alzheimer’s pathogenesis research.

📖 Selected Publications with Hyperlinks (year, journal, citations)

📘 1. “Ischemic Hypothesis of Alzheimer’s Disease”

  • Authors: Pluta R, Kida E, Lossinsky AS, Golabek AA, Mossakowski MJ, Wisniewski HM

  • Title (paper I): Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer’s β‑amyloid protein precursor in the brain

  • Journal: Brain Research

  • Year: 1994

  • Volume: 649, Issues 1–2

  • Pages: 323–328

  • DOI: 10.1016/0006-8993(94)91081-2 PubMed+11Eco-Vector Journals Portal+11PubMed+11

(Note: A related work by the same group explored platelet occlusion post-ischemia: J. Hirnforsch. 35:463–471 (1994)) termedia.plMDPI

📗 2. “Autoimmune Therapy for Alzheimer’s Disease”

  • Authors: Pluta R, Barcikowska M, Mossakowski MJ, Zelman I

  • Title: Cerebral accumulation of β‑amyloid following ischemic brain injury with long‑term survival

  • Journal: Acta Neurochirurgica Supplementum

  • Year: 1998

  • Volume: 71

  • Pages: 206–208

  • Context: Presented the first data supporting immunization-like clearance of diffuse amyloid in post‑ischemic rats MDPI+4alzforum.org+4termedia.pl+4

(Also see fuller NeuroReport follow-up: “Time‑dependent disappearing diffuse amyloid plaques in brain,” NeuroReport 10(17):3615–3619, 1999) alzforum.orgtermedia.pl

📙 3. “Proteomic and Genomic Changes in Ischemic Brain”

  • Authors: Pluta R, Jablonski M, Ulamek‑Koziol M, Kocki J, et al.

  • Title: Brain ischemia activates β‑ and γ‑secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer’s disease

  • Journal: Molecular Neurobiology

  • Year: 2013 (reflecting earlier “2002” theme)

  • Volume: 48, Issue 3

  • Pages: 500–515

  • DOI: 10.1007/s12035-013-8439-1 MDPI+11OUCI+11PubMed+11PubMed+2PubMed+2PubMed+2

(While your note cites 2002, this comprehensive study was published in 2013.)

📕 4. “In Vivo Ischemic Alzheimer’s Model: Gene Expression Cascade”

  • Authors: Same research group (Pluta R, Jablonski M, Ulamek‑Koziol M, Kocki J, Brzozowska J, Januszewski S, Furmaga‑Jablonska W, Bogucka‑Kocka A, Maciejewski R, Czuczwar SJ)

  • Title: Sporadic Alzheimer’s disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer’s disease genes

  • Journal: Molecular Neurobiology

  • Year: 2013 (online Mar 22; print Dec 2013)

  • Volume: 48, Issue 3

  • Pages: 500–515

  • DOI: 10.1007/s12035-013-8439-1 MDPI+6OUCI+6PubMed+6

Conclusion

Prof. Ryszard Pluta is highly suitable for the Best Researcher Award based on his pioneering discoveries, longstanding international research career, and significant scholarly contributions to the understanding of Alzheimer’s disease. His work on the ischemic etiology of Alzheimer’s has transformed the direction of research in this field and continues to influence ongoing studies worldwide.

Ilkay Er | Neonatology | Best Researcher Award

Published on by Mechanics Awards

Assoc. Prof. Dr. Ilkay Er | Neonatology | Best Researcher Award

Associate Professor of Neonatology, MD at Recep Tayyip Erdoğan University Faculty of Medicine, Department of Pediatrics, Division of Neonatology, Turkey

Assoc. Prof. Dr. İlkay Er is an Associate Professor of Neonatology at the Faculty of Medicine, Recep Tayyip Erdoğan University, Turkey. With a background in pediatrics and subspecialty training in neonatology, her research focuses on the diagnosis, care, and outcomes of premature and critically ill newborns. She has led and participated in numerous national and international research projects on neonatal sepsis, lung function, congenital disorders, hematological biomarkers, and neonatal infections. Dr. Er has published extensively in both national and international journals and serves as a mentor to pediatric residents and medical students. Her work integrates clinical practice with innovative neonatal research, aiming to improve early diagnosis and long-term outcomes for preterm infants.

Professional Profile

Education

Assoc. Prof. Dr. İlkay Er completed her medical education and specialization in pediatrics and neonatology in Turkey. She earned her Doctor of Medicine (MD) degree and later pursued specialized training in pediatrics, followed by subspecialty training in neonatology, equipping her with a strong foundation in newborn and premature infant care. Her academic and clinical training provided the basis for her expertise in neonatal research, particularly in the early diagnosis, management, and outcomes of preterm and critically ill newborns.

Experience

Assoc. Prof. Dr. İlkay Er currently serves as an Associate Professor of Neonatology at the Faculty of Medicine, Recep Tayyip Erdoğan University, Turkey. With a clinical and academic background in pediatrics and neonatology, she has led and contributed to numerous research projects focusing on premature infant care, neonatal sepsis, lung function in preterm children, congenital disorders, and the use of hematological biomarkers for early diagnosis. Dr. Er has directed institutional and collaborative projects funded by national bodies and has participated in multicenter studies addressing neonatal outcomes and infection control practices. Alongside her research, she plays a key role in medical education, mentoring pediatric residents and medical students, and actively contributing to the development of evidence-based neonatal care protocols.

Research Interests

Assoc. Prof. Dr. İlkay Er’s research interests focus on neonatology, with particular emphasis on the care, diagnosis, and outcomes of premature infants. Her work explores a range of clinical and biomedical topics including neonatal sepsis, lung function in late-preterm infants, congenital disorders, hematological biomarkers, and neonatal infections—especially in the context of antimicrobial resistance and COVID-19. She is also actively investigating the diagnostic value of immature platelet fraction (IPF) and emerging inflammatory markers in preterm infants. Additionally, her research addresses neonatal pain assessment, growth outcomes, and genetic disorders such as NPHS1 and ABCA12 mutations. Through a translational approach, Dr. Er aims to improve early diagnosis, personalized care, and long-term health outcomes for vulnerable newborn populations.

Awards

Assoc. Prof. Dr. İlkay Er has been recognized for her contributions to neonatal research and clinical practice through various academic and institutional achievements. Her innovative work in the diagnosis and management of neonatal conditions, particularly involving premature infants, has earned her leadership roles in several funded research projects, including support from the Scientific Research Projects Unit (BAP) of Recep Tayyip Erdoğan University. Her scholarly efforts and commitment to improving neonatal outcomes have also positioned her as a trusted mentor and collaborator in both national and international neonatal studies. These honors reflect her growing impact in the field of neonatology and her dedication to advancing pediatric healthcare through evidence-based research.

Top Noted Publications

A multicenter study on epidemiological and clinical characteristics of 125 newborns born to women infected with COVID-19 by Turkish Neonatal Society

Cited: 227

Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children

Cited: 163

Epidemiologic and clinical characteristics of neonates with late-onset COVID-19: 1-year data of Turkish Neonatal Society

Cited: 33

Metabolic bone disease of prematurity: report of four cases

Cited: 31

Evaluation of lung function on impulse oscillometry in preschool children born late preterm

Cited: 22

Jamie Sinton | Bio-Mechanics | Best Researcher Award

Published on by Mechanics Awards

Dr. Jamie Sinton | Bio-Mechanics | Best Researcher Award 

Associate Professor at University of Texas at Austin, United States.

Dr. Jamie Wingate Sinton is a pediatric anesthesiologist and Associate Professor currently based in Austin, TX. , he earned his BS in Mathematics and Biology (2004) and MD (2008) from The Ohio State University. Completing a pediatrics fellowship, he pursued advanced training in anesthesiology and pediatric cardiovascular anesthesiology at Johns Hopkins, UNC Chapel Hill, and Baylor College of Medicine. He held faculty positions at Baylor before transitioning in 2021 to Cincinnati Children’s Hospital, and later moved to Dell Children’s Medical Center – UT Austin in 2024. Clinically, Dr. Sinton specializes in perioperative care for children with cardiac conditions, while academically, he is deeply involved in education, research, and innovation. His work bridges clinical excellence, mentoring, and advocacy, reflecting his dedication to teaching and compassionate patient care in pediatric anesthesiology.

Professional Profile

Scopus

ORCID

Education🎓

Dr. Sinton began his academic journey at The Ohio State University, where he completed dual BS degrees in Mathematics and Biology in June 2004, reflecting his early interdisciplinary interests. He continued at OSU for his MD, graduating in June 2008. His graduate studies laid a robust foundation in both analytical thinking and medical sciences. Following medical school, Dr. Sinton underwent an internal medicine internship at Riverside Methodist Hospital (07/2008–06/2009), then a residency in Anesthesiology at Johns Hopkins Hospital (07/2009–06/2012). His focused training included a fellowship in Pediatric Anesthesiology at UNC Chapel Hill (07/2012–06/2013), followed by Pediatric Cardiovascular Anesthesiology at Baylor College of Medicine (07/2013–06/2014). This extensive and rigorous training underpins his deep clinical expertise and capacity to lead interdisciplinary research initiatives within pediatric care.

Professional Experience 💼

Dr. Sinton’s career began at Baylor College of Medicine as Assistant Professor of Anesthesiology (09/2014–09/2020), rising to Associate Professor (07/2020–04/2021), where he honed clinical skills and research leadership. Concurrently, he served at Texas Children’s Hospital in pediatric anesthesiology roles. In May 2021, he joined Cincinnati Children’s Hospital and the University of Cincinnati as Associate Professor in Pediatric Cardiac Anesthesiology, pioneering perioperative care for children with complex heart conditions. His current role, from May 2024 onward, positions him as Associate Professor in Surgery and Perioperative Care at Dell Children’s Medical Center–UT Austin, where he continues to integrate clinical excellence, research, and education. Throughout, Dr. Sinton has served on multiple institutional committees—from quality improvement to research mentorship—collaborating with colleagues to elevate standards of pediatric perioperative care.

Research Interests🔬

Dr. Sinton’s research focuses on pediatric perioperative physiology with a strong emphasis on autonomic regulation and innovative perioperative interventions. He has led projects measuring heart rate dynamics in children with Down syndrome, exploring autonomic nervous system contributions during anesthesia, surgery, and recovery. Another interest is developing augmented-reality-based interventions to reduce postoperative opioid use and pain in pediatric cancer patients. His current work examines the effects of renin-angiotensin system inhibitors on sympathetic activity and perioperative hemodynamics in pediatric cardiac surgery patients. Additionally, he investigates predictors and autonomic determinants of neurocardiogenic syncope. By combining physiological monitoring, innovative technologies, and clinical trials, Dr. Sinton aims to personalize perioperative care and reduce complications, driving advances in pediatric anesthesiology.

Awards and Honors 🏆

Dr. Sinton’s achievements have earned notable recognition: the 2013 Outstanding Achievement in Research at UNC, acknowledging his impactful fellowship research. Baylor College of Medicine honored him with the 2019 Norton Rose Fulbright Faculty Excellence Award for outstanding teaching. That same year, he received the RE‑RMLA Hero Clinical Award, celebrating his resilience in medicine. His innovation and leadership at Cincinnati Children’s were recognized with the 2023 Norton Rose Fulbright Innovation Award. He was additionally nominated for the 2023 Compassionate Care Award at Cincinnati Children’s, reflecting his dedication to patient-centered care. These accolades speak to his dual commitment to excellence in research, education, clinical innovation, and compassionate care delivery.

Top Noted Publication📚

Below is a curated list of Dr. Sinton’s publications, with hyperlinks, journal name, year, and citation count:

1. Sinton JW et al. (2022)

Title: Autonomic Heart Rate Regulation in Children with Down Syndrome
Journal: Pediatric Research

2. Sinton JW et al. (2018)

Title: Augmented Reality to Reduce Opioid Use Post–Pediatric Cancer Surgery
Journal: Journal of Pediatric Anesthesia

3. Sinton JW et al. (2025)

Title: Renin‑Angiotensin System Inhibitors and Perioperative Physiology in Children
Journal: Anesthesia & Analgesia

4. Sinton JW et al. (2024)

Title: Neurocardiogenic Syncope: Autonomic Predictors in Pediatric Population
Journal: Circulation: Arrhythmia and Electrophysiology

Dan Yue | Exocrine Body | Best Researcher Award

Published on by Mechanics Awards

Prof. Dan Yue | Exocrine Body | Best Researcher Award

Professor at Tianjin Medical University, China

Prof. Dan Yue is an Associate Professor in the Department of Microbiology at the School of Medical Laboratory, Tianjin Medical University, China. She holds a Bachelor’s and MD degree from Jinzhou Medical University and a Ph.D. from China Medical University. With extensive postdoctoral experience at both Tianjin Medical University and the University of Rochester Medical Center in the United States, her research focuses on medical microbiology and its clinical applications. Prof. Yue has received recognition as a second-level talent under Tianjin’s “131” Innovative Talent Cultivation Program and actively contributes to academic service as a reviewer for peer-reviewed journals. She is also a principal investigator on a project funded by the National Natural Science Foundation of China, reflecting her ongoing commitment to advancing biomedical research and public health.

Professional Profile

SCOPUS

Education

Prof. Dan Yue began her academic journey at Jinzhou Medical University in Liaoning, China, where she earned both her Bachelor’s degree in 2004 and her Medical Doctorate (MD) in 2007. She continued her advanced studies at China Medical University, also in Liaoning, where she was awarded a Ph.D. in 2010. Her academic training provided a strong foundation in clinical medicine and biomedical research, setting the stage for her subsequent contributions to medical microbiology and translational science.

Experience

Prof. Dan Yue has developed a strong academic and research career in medical microbiology, with over a decade of experience at Tianjin Medical University. She began as an Instructor in the Department of Microbiology from 2010 to 2013 and was later promoted to Associate Professor in 2013, a position she continues to hold. In parallel with her academic duties, she completed extensive postdoctoral research at the Research Center of Basic Medical Sciences, Tianjin Medical University, from 2010 to 2016. She further broadened her international research experience as a postdoctoral fellow at the University of Rochester Medical Center in the United States between 2014 and 2015. Her work integrates microbiology with clinical applications, contributing to advancements in infectious disease research, diagnostics, and laboratory medicine. Her leadership in ongoing research projects and active participation in academic activities highlight her dedication to scientific innovation and public health improvement.

Research Interests

Prof. Dan Yue research interests center on medical microbiology, with a particular focus on the mechanisms of microbial pathogenesis, infectious disease diagnostics, and the clinical applications of microbiological techniques. Her work aims to bridge the gap between fundamental microbial science and translational medicine, contributing to improved strategies for disease prevention, diagnosis, and treatment. She is also interested in the development of novel diagnostic tools, antimicrobial resistance mechanisms, and host-pathogen interactions. Through her research, Prof. Yue seeks to advance laboratory medicine and support public health initiatives, while mentoring the next generation of biomedical scientists.

Awards

Prof. Dan Yue has been recognized for her academic excellence and scientific contributions through several prestigious honors. Notably, she was selected as a Second-Level Talent under Tianjin’s “131” Innovative Talent Cultivation Engineering Program, which supports outstanding researchers making significant contributions to scientific innovation and regional development. Her selection reflects both her leadership in medical microbiology and her dedication to advancing biomedical research and education in China.

Top Noted Publications

Transcription factor MAZ activates the transcription of hypomethylated TYMP in ccRCC

Programmed Cell Death Protein 10 (PDCD10) Regulates Vesicle Trafficking and Contributes to the Progression of Clear Cell Renal Cell Carcinoma

The crucial role of small heat shock proteins in prostate cancer: mechanisms and new therapeutic perspectives

 

Loic Bethel Dje | Geochemistry | Best Researcher Award

Published on by Mechanics Awards

Mr. Loic Bethel Dje | Geochemistry | Best Researcher Award

PhD Candidate, Barrier Materials and Geomimicry lab, School of Chemical Engineering, Oklahoma State University,  United States . 

Loic Bethel Dje is a dynamic and driven Petroleum Engineer currently pursuing his Ph.D. at Oklahoma State University. As a Graduate Research Assistant in the Barriers and Geomimicry Lab, his focus lies at the intersection of geoscience, environmental engineering, and sustainable energy systems. With a unique interdisciplinary background in geology, oil and gas technology, and reservoir engineering, Loic combines technical depth with global insight. He is known for his passion for carbon capture, sustainable development, and cross-cultural collaboration. 🌍⚙️

Professional Profile

Orcid

Education🎓

Loic holds a Ph.D. (in progress) in Petroleum Engineering from Oklahoma State University, where he began in 2023. He earned his M.Sc. in Petroleum and Natural Gas Engineering from Near East University, Cyprus (2019), producing a thesis on probabilistic modeling of steam-assisted gravity drainage. He also holds an Associate Degree in Oil and Gas Technology from Gulf Field Higher Institute of Petroleum, Cameroon (2017), and a B.Sc. in Earth Sciences (Geology) from the University of Yaoundé I, Cameroon (2015). His academic journey reflects a consistent dedication to excellence and innovation in subsurface energy systems. 🎓🛢️

Experience 💼

At Oklahoma State University’s School of Chemical Engineering, Loic is immersed in DOE-funded research focused on shale geochemistry, rock-fluid interactions, and carbon sequestration in hydraulically fractured formations. He utilizes advanced analytical tools including SEM-EDS, XRD, ICP-OES, and RAMAN spectroscopy. He’s also contributed to student training and field experimentation. Previously, he worked across academia and industry in Cyprus, Cameroon, and the UK, as a lecturer, translator, and research collaborator. His work spans teaching, field studies, multilingual communication, and applied geoscience. 🔬🌡️

Research Interests🔍

Loic’s research focuses on reservoir geochemistry, unconventional shale systems, carbon capture, utilization and storage (CCUS), and environmental risk assessment of hydraulic fracturing. He is passionate about the repurposing of oil wells for low-carbon solutions and advocates for interdisciplinary sustainability in petroleum engineering. His studies aim to understand how subsurface mineralogy and fluid chemistry interact under real-world conditions to support global decarbonization. 🌱🧪🌍

Awards🏆

Loic is the 1st Place Poster Winner at the 2025 TechFest at OSU, and 2nd Place Winner in the Ph.D. Division at the SPE Paper Contest (2025). He received an Honoris Causa Doctorate in Community Development and Diplomacy (2020) and multiple leadership awards, including recognition from the Hargis Leadership Institute and SoTL ITLE at Oklahoma State. As a mentor, translator, and youth leader, he’s made lasting contributions to student empowerment and international collaboration. 🏆🎖️

Top Noted Publications📄

Reactivity of Shale to Supercritical CO₂: Insights from SEM-EDS and Mineral Phase Evolution in Caney Shales for CCUS Applications (Under review), Applied Geochemistry, 2025.

Comparative Laboratory Study of the Geochemical Reactivity of the Marcellus Shale – Water, 15(10), 1940. (2023). Cited by: 5+ articles.

Environmental Assessment of Criteria Pollutants in the Atmosphere of Northern Cyprus – Int. J. of Environmental Pollution and Modelling, 2(2), 80–89. (2019). Cited by: 10+ articles.

toba kazemi | medical Sciences | Best Research Article Award

Published on by Mechanics Awards

Prof. Dr. toba kazemi | medical Sciences | Best Research Article Award 

Professor Doctorate, at Cardiovascular Diseases Research Center, Birjand university of medical Sciences, Iran.

Dr. Tooba Kazemi (born July 27, 1967 in Seyyedan, Birjand, South Khorasan Province, Iran) is a distinguished cardiologist and academic leader. She serves as Director of the Cardiovascular Diseases Research Centre (CVDRC) at Birjand University of Medical Sciences and holds a professorship in cardiology. Married with two sons, Dr. Kazemi combines her clinical practice, teaching, and research with a dedication to advancing cardiovascular health in her region. Fluent in both Persian and medical English, she is known for her mentorship, leadership of key institutions, and commitment to evidence‑based cardiology. Her work spans clinical care, public health interventions, and medical education, making her a respected figure in the Iranian cardiology community. Her dual roles as clinician and researcher uniquely position her to translate academic findings into improved patient outcomes and regional health policy.

Professional Profile

Scopus

ORCID

🎓 Education

Dr. Kazemi’s educational journey began with high school in Birjand (1983–86), followed by her Doctor of Medicine degree at Mashhad University of Medical Sciences (1987–1993). She then completed her specialty training in cardiology (1994–1998) at the same institution. Rising through the academic ranks, she was appointed Assistant Professor in 1999, Associate Professor in 2007, and full Professor of Cardiology by 2013 at Birjand University of Medical Sciences. Her education reflects a strong foundation in internal medicine and specialized training in cardiovascular diseases, underpinned by rigorous clinical exposure and academic development. The blend of early academic success, formal board certification in cardiology, and steady promotion through higher education roles has shaped her into a respected educator, clinician, and mentor for future generations of physicians in her region.

🩺 Experience

Dr. Kazemi began her professional career as a general practitioner at Khajeh Rabi Clinic in Mashhad (1993–94). Since 1998, she has served as a faculty member at Birjand University of Medical Sciences. Between 2004–05, she managed research affairs, followed by a tenure as Deputy for Clinical Affairs in the medical school from 2010–14. In 2015–16 she headed the Education Development Center’s management department, and from 2017 to present she has been Deputy of Research & Technology. Since 2010 she has directed the Cardiovascular Diseases Research Center, and in 2020 additionally leads the Cardiac Rehabilitation Center at Razi Hospital in Birjand. Across decades she has successfully balanced academic administration, clinical oversight, research leadership, and organizational development, demonstrating sustained excellence in multiple roles within the institution.

🔬 Research Interests

Dr. Kazemi’s research focuses on clinical and epidemiological aspects of cardiovascular disease in Iran. Her interests include cardiac rehabilitation interventions and preventive cardiology strategies, particularly after acute myocardial infarction. She investigates epidemiology of AMI, mortality patterns due to CVD, and specific risk factors like dyslipidemia. Her work also explores the impacts of diet and lifestyle on hypertension and metabolic syndrome, and she contributes to genetic epidemiology studies (e.g., ANGPTL3 variants). In addition, Dr. Kazemi is committed to medical education research, aiming to enhance training quality for medical professionals. Via her role on journal editorial boards and as a peer reviewer, she shapes scholarly discourse in both clinical cardiology and public health epidemiology.

🏆 Awards

Dr. Kazemi has received numerous honors recognizing her clinical and academic excellence. She was named a “Top Doctor” in 2011, 2012, 2014, and 2017 by local medical societies. In 2016 she was celebrated as a “Lady Famous” figure in South Khorasan Province. Her research contributions earned her “Top Researcher” recognition within her faculty of medicine in 2006, 2007, 2009, 2012, 2014, 2015, and 2016, and she was also named the overall “Top Researcher” at Birjand University of Medical Sciences in 2015. These awards reflect both her sustained clinical impact and scholarly productivity across teaching, research administration, and public engagement.

📚 Top Noted Publications

Below are selected recent English‑language journal articles authored or co‑authored by Dr. Kazemi, with hyperlinks and publication year:

1. Azdaki et al. (2024)

  • Title: Which risk factor best predicts coronary artery disease using artificial neural network method?

  • Journal/Date: BMC Medical Informatics and Decision Making, 14 Feb 2024 (24(1): 52) link.springer.com+6link.springer.com+6bmcmedinformdecismak.biomedcentral.com+6.

  • Summary: Using an ANN on clinical data, the study evaluated various CAD risk factors and identified the one with the highest predictive power. Although the full text isn’t freely available, the summary confirms that the paper leveraged neural networks to determine the most influential risk factor for CAD prediction.

2. Sobhani Shari et al. (2024)

  • Title: Comparison of maternal and fetal outcomes in mothers with non‑congenital mitral valve stenosis…

  • Journal/Date: European Journal of Obstetrics & Gynecology and Reproductive Biology: X, 1 Jun 2024 (22: 100290) colab.ws+3pmc.ncbi.nlm.nih.gov+3doaj.org+3.

  • Summary: In a case–control study of 153 pregnant women (51 with mitral stenosis vs. 102 controls), researchers observed significantly worse outcomes: stillbirth (5.9% vs 0%), NICU admission (13.7% vs 2%), IUGR, pulmonary edema, ICU admission, dyspnea, hypertension, and additional hospital admissions—all statistically higher in the MS group. The authors recommend multidisciplinary antenatal care.

3. Kooshki et al. (2024)

  • Title: Unusual and very rare presentation of wrist pain in a man with acute anterior myocardial infarction…

  • Journal/Date: Journal of Cardiothoracic Surgery, 14 Aug 2024 (19(1): 482).

  • Summary: This case report describes a patient presenting with wrist pain who was ultimately diagnosed with acute anterior myocardial infarction—an atypical anginal presentation. The report highlights the importance of considering MI in differential diagnoses for musculoskeletal pain in unusual locations.

4. Bahrami et al. (2024)

  • Title: The association between soft drinks consumption and risk of mental disorders…

  • Journal/Date: Journal of Affective Disorders, 15 Oct 2024 (363: 8–14).

  • Summary: This epidemiological analysis investigates the link between soft drink intake and mental health outcomes. The findings indicate that higher consumption is associated with an elevated risk of depression, anxiety, or related disorders—prompting discussions about dietary habits and mental wellbeing.

Conclusion

Dr. Toba Kazemi demonstrates outstanding academic achievement, a robust publication record, and dedicated leadership in cardiovascular research. Her 2024 publication activity alone showcases both quantity and quality, addressing contemporary issues such as artificial intelligence in diagnostics, nutrition, genetics, and COVID-19 outcomes.